A detailed history of Apollon Financial, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Apollon Financial, LLC holds 2,214 shares of JNJ stock, worth $343,546. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,214
Previous 2,090 5.93%
Holding current value
$343,546
Previous $306 Million 17.45%
% of portfolio
0.11%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$145.48 - $167.38 $18,039 - $20,755
124 Added 5.93%
2,214 $359 Million
Q2 2024

Jul 19, 2024

SELL
$144.38 - $157.78 $4,764 - $5,206
-33 Reduced 1.55%
2,090 $306 Million
Q1 2024

May 02, 2024

BUY
$155.22 - $162.74 $6,829 - $7,160
44 Added 2.12%
2,123 $336 Million
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $302,702 - $330,311
2,079 New
2,079 $326 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Apollon Financial, LLC Portfolio

Follow Apollon Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Financial, LLC with notifications on news.